Neurocrine Biosciences Inc (NASDAQ:NBIX)

Delayed Data
As of May 25
 -0.44 / -0.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 104.00, with a high estimate of 139.00 and a low estimate of 100.00. The median estimate represents a +10.40% increase from the last price of 94.20.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 69.66%
Growthannually 85.99%


Growthquarterly 18.69%
Growthannually 145.27%
Key to the earnings and sales forecast charts.